Skip to main content
. 2021 Sep 14;28(1):1877–1889. doi: 10.1080/10717544.2021.1974608

Figure 7.

Figure 7.

Microbiological observations of therapeutic efficacy of the optimized VCZ loaded MLNCs formulation, drug-free MLNCs formulation, and VCZ suspension against vaginal candidiasis in female Wistar rats. Data represented as the mean of log10 CFU/ml and the error bars represent the standard error (n = 5). The first day on the graph corresponds to the third day of inoculation. Statistical analysis was performed by applying analysis of variance (ANOVA) at p-value < .05. The * marks the significant repression in log10 CFU/ml compared to the control. The ** marks the significant repression in log10 CFU/ml compared to the drug suspension.